Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas (0908-09)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Kent Robertson, Indiana University School of Medicine
ClinicalTrials.gov Identifier:
NCT01140360
First received: June 8, 2010
Last updated: August 4, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)